SAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (AMBX), (NYSE: AMAM), a clinical stage biopharmaceutical company using its proprietary Engineered Precision Biologics (EPBs) ...
SABCS® “Spotlight” poster to be presented on Wednesday, December 11, 2024 7:00 AM – 8:30 AM CST highlights positive BriaCell survival and clinical benefit data across all metastatic breast cancer ...
Following the presentation, copies of the posters will be posted on https://briacell.com/scientific-publications/. About BriaCell Therapeutics Corp. BriaCell is a ...
PHILADELPHIA and VANCOUVER, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results